1 Clinical Study: Design and Methods Hail M. Al-Abdely, MD Consultant, Infectious Diseases King Faisal Specialist Hospital & Research Centre.
1 Pegaptanib Benefit Risk Profile Donald J. D ’ Amico, MD Harvard Medical School Massachusetts Eye and Ear Infirmary FDA Advisory Panel August 27, 2004.
Infectious Diseases Review Course Hail M. Al-Abdely, MD Consultant, Infectious Diseases.
Glycopeptides, Oxazolidinones, Streptogramins and Aminoglycosides Hail M. Al-Abdely, MD Consultant, Adult Infectious Diseases King Faisal Specialist Hospital.
Efficacy and Safety of Vernakalant Hydrochloride Injection for the Treatment of Atrial Fibrillation After Valvular or Coronary Artery Bypass Surgery Peter.
New Perspectives and Emerging Treatment Paradigms for Individualizing Obesity Management
Sonographic Evaluation of MAGEC Growing Scoliosis Rods in Pediatric Patients Cincinnati Children’s Hospital Medical Center Department of Orthopaedics Department.